Evaluation of the Diagnostic Utility of Selected Serum Adipokines and Cytokines in Subjects with MASLD—A Pilot Study.

Excess adipose tissue, particularly of the visceral type, triggering chronic low-grade inflammation and altering its secretory profile, is a contributing factor to the initiation and progression of metabolic dysfunction-associated steatotic liver disease (MASLD). This study aimed to compare the leve...

Descripción completa

Detalles Bibliográficos
Publicado en:Nutrients Vol. 16; no. 9; pp. 1381 - 1398
Autores principales: Zyśk, Beata, Ostrowska, Lucyna, Smarkusz-Zarzecka, Joanna, Orywal, Karolina, Mroczko, Barbara, Cwalina, Urszula
Formato: research tables/charts Journal Article
Publicado: MDPI May2024
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=177180021&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 177180021
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        20726643
        B0TT
      jtl: Nutrients
      issn: 20726643
      maglogo: N
    pubinfo:
      dt: May2024
      vid: 16
      iid: 9
      pid: 97109
      pub: MDPI
    artinfo:
      ui:
        177180021
        177180021
        177180021
        10.3390/nu16091381
        177180021
      ppf: 1381
      ppct: 17
      formats:
      tig:
        atl: Evaluation of the Diagnostic Utility of Selected Serum Adipokines and Cytokines in Subjects with MASLD—A Pilot Study.
      aug:
        au:
          Zyśk, Beata
          Ostrowska, Lucyna
          Smarkusz-Zarzecka, Joanna
          Orywal, Karolina
          Mroczko, Barbara
          Cwalina, Urszula
        affil: Department of Dietetics and Clinical Nutrition, Medical University of Bialystok, Mieszka I 4B Street, 15-054 Bialystok, Poland
      sug:
        subj:
          Nonalcoholic Fatty Liver Disease Diagnosis
          Metabolic Diseases Complications
          Nonalcoholic Fatty Liver Disease Risk Factors
          Adipokines Blood
          Cytokines Blood
          Adipokines Diagnostic Use
          Cytokines Diagnostic Use
          Risk Assessment
          Obesity
          Human
          Female
          Male
          Nonexperimental Studies
          Pilot Studies
          Adipose Tissue
          Body Mass Index
          Body Composition
          Interleukins Blood
          Matrix Metalloproteinases Blood
          Analysis of Variance
          Multivariate Analysis
          Regression
          Kruskal-Wallis Test
          Data Analysis Software
          ROC Curve
          Confidence Intervals
          Descriptive Statistics
          Funding Source
          Female
          Male
      ab: Excess adipose tissue, particularly of the visceral type, triggering chronic low-grade inflammation and altering its secretory profile, is a contributing factor to the initiation and progression of metabolic dysfunction-associated steatotic liver disease (MASLD). This study aimed to compare the levels of selected adipokines and cytokines in individuals with normal weight and obesity, assessing their potential for diagnosing MASLD and establishing a cutoff point for body fat content associated with hepatic steatosis development. The research involved 99 participants categorized by body mass index and MASLD presence, undergoing body composition analysis, liver elastography, biochemical tests, and evaluation of adipokines and cytokines in serum. The results indicated elevated IL-6 (interleukin 6) serum levels in individuals with obesity with MASLD compared to the normal-weight group without MASLD. The multivariate regression analysis demonstrated a connection between hepatic steatosis and total adipose tissue content, VAT (visceral adipose tissue), VAT/SAT (subcutaneous adipose tissue) ratio, HOMA-IR (homeostasis model assessment of insulin resistance), IL-6, Il-1β (interleukin 1β), and MMP-2 (matrix metalloproteinase 2). Among the adipokines and cytokines examined in this study, interleukin 6 was the strongest predictor of MASLD regardless of gender. In addition, an association between the development of hepatic steatosis and higher serum IL-1β levels and higher adipose tissue was observed in women. However, further studies on a larger group of patients are needed to consider the use of these cytokines as markers of MASLD. The HOMA-IR index demonstrated potential diagnostic utility in identifying hepatic steatosis.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N